rs237025

Variant summary

Our verdict is Benign.
-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -10 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Moderate

The NM_001002255.2(SUMO4):c.163G>A (p.Val55Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.513 (AC=828,175) in the gnomAD database across 1,613,990 control chromosomes, including 216,559 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.721. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars). This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.57 ( 25727 hom., cov: 33)
Exomes 𝑓: 0.51 ( 190832 hom. )

Consequence

SUMO4
NM_001002255.2 missense

Scores

15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2B:5

Conservation

PhyloP100: 0.259

Publications

145 publications found
Variant links:
Genes affected
SUMO4 (HGNC:21181): (small ubiquitin like modifier 4) This gene is a member of the SUMO gene family. This family of genes encode small ubiquitin-related modifiers that are attached to proteins and control the target proteins' subcellular localization, stability, or activity. The protein described in this record is located in the cytoplasm and specifically modifies IKBA, leading to negative regulation of NF-kappa-B-dependent transcription of the IL12B gene. A specific polymorphism in this SUMO gene, which leads to the M55V substitution, has been associated with type I diabetes. The RefSeq contains this polymorphism. [provided by RefSeq, Jul 2008]
SUMO4 Gene-Disease associations (from GenCC):
  • type 1 diabetes mellitus 5
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2 Gene-Disease associations (from GenCC):
  • chromosome 6q24-q25 deletion syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • congenital heart defects, multiple types, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Illumina, Laboratory for Molecular Medicine
  • polyvalvular heart disease syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001002255.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -10 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7213 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001002255.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUMO4
NM_001002255.2
MANE Select
c.163G>Ap.Val55Met
missense
Exon 1 of 1NP_001002255.1Q6EEV6
TAB2
NM_001292034.3
MANE Select
c.1939+1370G>A
intron
N/ANP_001278963.1Q9NYJ8-1
TAB2
NM_001369506.1
c.1939+1370G>A
intron
N/ANP_001356435.1Q9NYJ8-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUMO4
ENST00000326669.6
TSL:6 MANE Select
c.163G>Ap.Val55Met
missense
Exon 1 of 1ENSP00000318635.4Q6EEV6
TAB2
ENST00000637181.2
TSL:1 MANE Select
c.1939+1370G>A
intron
N/AENSP00000490618.1Q9NYJ8-1
TAB2
ENST00000470466.5
TSL:1
n.*538+1370G>A
intron
N/AENSP00000432709.1Q9NYJ8-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.572
AC:86908
Hom:25691
AN:152006
Cov:33
GnomAD2 exomes
AF: 0.554
AC:139242
AN:251486
GnomAD4 exome
AF: 0.507
AC:741165
Hom:190832
AN:1461864
Cov:70
GnomAD4 genome
AF: 0.572
AC:87010
Hom:25727
AN:152126
Cov:33
TOPMed (Bravo)
AF: 0.584
AC:154498
Hom:46637
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.522
AC:166853
Hom:44676
AN:319760
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.528
AC:1236
Hom:331
AN:2342
ChinaMAP Phase 1
AF: 0.711
Denmark Genome
AF: 0.510
AC:151
AN:296
ESP6500 (Exome Variant Server)
AF: 0.562
AC:7308
AN:13006
GenomeAsia100K
AF: 0.717
AC:2491
AN:3478
Korea4K (4,157 Koreans)
AF: 0.680
AC:4918
AN:7234
Qatari Genome
AF: 0.482
AC:968
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.684
AC:84001
Hom:28764
AN:122814
Turkish Variome
AF: 0.481
AC:3231
Hom:785
AN:6724
UK10K
AF: 0.490
AC:3702
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.707
AC:6337
Hom:2227
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.532 *590711112 0.524 *922517616
BipEx
(Bipolar disorder (including schizoaffective))
0.492 1397628420 0.491 1415928844
Epi25
(Epilepsy)
0.530 2222341958 0.522 3488366888
SCHEMA
(Schizophrenia)
0.588 96632164316 0.580 158145272560
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
1
Type 1 diabetes mellitus 5 (3)
-
-
2
not specified (2)
-
-
1
Diabetes mellitus type 1 (1)
-
-
1
not provided (1)

Computational Scores

AlphaGenome AVI
Uncertain10
AlphaMissense
Benign0.097
BayesDel_addAF
Benign-0.82T
BayesDel_noAF
Benign-0.80
CADD
Benign0.070
DANN
Benign0.31
Eigen
Benign-1.3
Eigen_PC
Benign-1.5
FATHMM_MKL
Benign0.11N
FuncVEP CTI
Benign0.028
GPN-Star LLR
N/A-1.2
GPN-Star score
N/A1.2
MetaRNN
Benign0.0000010T
MetaSVM
Benign-0.97T
Mutation Taster
N/A92/8disease causing (ClinVar)
PhyloP100
Benign0.26
popEVE
Benign-2.0
PrimateAI
Benign0.35T
PromoterAI
N/A-0.0074Neutral
PROVEAN
Benign2.5N
REVEL
Benign0.079
Sift
Benign1.0T
Sift4G
Benign1.0T
VESM-3B
Benign-4.1
Showing 24 of 24 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.030
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.